HDAC抑制剂-话题@MedSci

#HDAC抑制剂#

11篇内容 | 1138人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1755768, encodeId=9dd51e557685f, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=Clin Cancer Res：HDAC抑制剂Remetinostat凝胶用于基底细胞癌的治疗活性, objectType=article, longId=216890, objectId=3239216890aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3239216890aa, replyNumber=0, likeNumber=64, createdTime=2022-02-10, rootId=0, userName=anan, userId=48c937021427, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3239216890aa, moduleTitle=Clin Cancer Res：HDAC抑制剂Remetinostat凝胶用于基底细胞癌的治疗活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3239216890aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755765, encodeId=b97f1e5576529, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=Sci Transl Med：HDAC抑制剂SAHA可改善心衰患者的心脏结构和功能, objectType=article, longId=186158, objectId=6a4918615898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a4918615898, replyNumber=0, likeNumber=89, createdTime=2020-04-08, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a4918615898, moduleTitle=Sci Transl Med：HDAC抑制剂SAHA可改善心衰患者的心脏结构和功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a4918615898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755767, encodeId=e8871e557676f, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=张清媛教授专访：从淋巴瘤到乳腺癌，HDAC抑制剂西达本胺在实体肿瘤迎来突破, objectType=article, longId=194406, objectId=5ae119440659, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ae119440659, replyNumber=0, likeNumber=80, createdTime=2020-05-28, rootId=0, userName=anan, userId=48c937021427, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ae119440659, moduleTitle=张清媛教授专访：从淋巴瘤到乳腺癌，HDAC抑制剂西达本胺在实体肿瘤迎来突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ae119440659)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755766, encodeId=fceb1e5576653, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤, objectType=article, longId=187714, objectId=782818e714bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=782818e714bf, replyNumber=0, likeNumber=90, createdTime=2020-03-21, rootId=0, userName=anan, userId=48c937021427, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=782818e714bf, moduleTitle=Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=782818e714bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755763, encodeId=be031e5576392, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=Viracta的HDAC抑制剂nanatinostat治疗EBV相关癌症，获得美国FDA的孤儿药物指定, objectType=article, longId=164502, objectId=df0c164502be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df0c164502be, replyNumber=0, likeNumber=74, createdTime=2019-06-23, rootId=0, userName=anan, userId=48c937021427, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df0c164502be, moduleTitle=Viracta的HDAC抑制剂nanatinostat治疗EBV相关癌症，获得美国FDA的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df0c164502be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755764, encodeId=3bff1e5576490, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=Xynomic公司宣布其HDAC抑制剂Abbexinostat与Keytruda联合治疗多种实体瘤的阳性1b期研究中期数据, objectType=article, longId=178550, objectId=07b01e855010, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07b01e855010, replyNumber=0, likeNumber=72, createdTime=2020-06-22, rootId=0, userName=anan, userId=48c937021427, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07b01e855010, moduleTitle=Xynomic公司宣布其HDAC抑制剂Abbexinostat与Keytruda联合治疗多种实体瘤的阳性1b期研究中期数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07b01e855010)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755759, encodeId=81821e5575956, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=揭示HDAC抑制剂实体瘤治疗失败机制, objectType=article, longId=78071, objectId=8bbee807100, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bbee807100, replyNumber=0, likeNumber=68, createdTime=2017-04-21, rootId=0, userName=anan, userId=48c937021427, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bbee807100, moduleTitle=揭示HDAC抑制剂实体瘤治疗失败机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bbee807100)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755762, encodeId=522c1e557629f, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=Cancer Res：HDAC抑制剂可促进单抗药物对HER2阳性肿瘤的治疗效果, objectType=article, longId=90949, objectId=ebb19094974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebb19094974, replyNumber=0, likeNumber=75, createdTime=2017-07-30, rootId=0, userName=anan, userId=48c937021427, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebb19094974, moduleTitle=Cancer Res：HDAC抑制剂可促进单抗药物对HER2阳性肿瘤的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebb19094974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755760, encodeId=05801e55760ad, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=Cancer Cell：研究揭示HDAC抑制剂实体瘤治疗失败机制, objectType=article, longId=78169, objectId=49ace8169e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49ace8169e0, replyNumber=0, likeNumber=53, createdTime=2016-12-14, rootId=0, userName=anan, userId=48c937021427, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49ace8169e0, moduleTitle=Cancer Cell：研究揭示HDAC抑制剂实体瘤治疗失败机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49ace8169e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755761, encodeId=51a11e5576131, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=中科院上海药物所研究揭示HDAC抑制剂实体瘤治疗失败机制, objectType=article, longId=78179, objectId=645fe8179c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=645fe8179c4, replyNumber=0, likeNumber=67, createdTime=2016-10-20, rootId=0, userName=anan, userId=48c937021427, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=645fe8179c4, moduleTitle=中科院上海药物所研究揭示HDAC抑制剂实体瘤治疗失败机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=645fe8179c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755758, encodeId=7e461e5575871, content=<a href='/topic/show?id=539986058d' target=_blank style='color:#2F92EE;'>#HDAC抑制剂#</a>, objectTitle=重磅！诺华抗癌药Farydak获FDA批准，系治疗多发性骨髓瘤的HDAC抑制剂, objectType=article, longId=47498, objectId=7e584e4988f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e584e4988f, replyNumber=0, likeNumber=97, createdTime=2015-03-08, rootId=0, userName=anan, userId=48c937021427, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e584e4988f, moduleTitle=重磅！诺华抗癌药Farydak获FDA批准，系治疗多发性骨髓瘤的HDAC抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e584e4988f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HDAC抑制剂

2020-05-29

anan (审核中...)

前往app查看评论内容

#HDAC抑制剂#

Clin Cancer Res：HDAC抑制剂Remetinostat凝胶用于基底细胞癌的治疗活性

2022-02-10

柳叶一刀 (审核中...)

前往app查看评论内容

#HDAC抑制剂#

Sci Transl Med：HDAC抑制剂SAHA可改善心衰患者的心脏结构和功能

2020-04-08

anan (审核中...)

前往app查看评论内容

#HDAC抑制剂#

张清媛教授专访：从淋巴瘤到乳腺癌，HDAC抑制剂西达本胺在实体肿瘤迎来突破

2020-05-28

anan (审核中...)

前往app查看评论内容

#HDAC抑制剂#

Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤

2020-03-21

anan (审核中...)

前往app查看评论内容

#HDAC抑制剂#

Viracta的HDAC抑制剂nanatinostat治疗EBV相关癌症，获得美国FDA的孤儿药物指定

2019-06-23

anan (审核中...)

前往app查看评论内容

#HDAC抑制剂#

Xynomic公司宣布其HDAC抑制剂Abbexinostat与Keytruda联合治疗多种实体瘤的阳性1b期研究中期数据

2020-06-22

anan (审核中...)

前往app查看评论内容

#HDAC抑制剂#

揭示HDAC抑制剂实体瘤治疗失败机制

2017-04-21

anan (审核中...)

前往app查看评论内容

#HDAC抑制剂#

Cancer Res：HDAC抑制剂可促进单抗药物对HER2阳性肿瘤的治疗效果

2017-07-30

anan (审核中...)

前往app查看评论内容

#HDAC抑制剂#

Cancer Cell：研究揭示HDAC抑制剂实体瘤治疗失败机制

2016-12-14

anan (审核中...)

前往app查看评论内容

#HDAC抑制剂#

中科院上海药物所研究揭示HDAC抑制剂实体瘤治疗失败机制

2016-10-20

anan (审核中...)

前往app查看评论内容

#HDAC抑制剂#

重磅！诺华抗癌药Farydak获FDA批准，系治疗多发性骨髓瘤的HDAC抑制剂

2015-03-08

科室
- - 订阅+
  - 更多科室
工具
服务